SCHEMBL7012612

SCHEMBL7012612

O=C1Nc2ccccc2-c2ccccc2N1C1CCNCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 5/20 0.45
HTR2B P41595 4/20 0.45
HTR2A P28223 3/20 0.45
OPRM1 P35372 2/20 0.37
OPRD1 P41143 2/20 0.37
OPRK1 P41145 2/20 0.37
OPRL1 P41146 1/20 0.37
DRD2 P14416 1/20 0.36
SLC6A4 P31645 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP3A5 P20815 2/20 0.36
CYP3A7 P24462 2/20 0.36
CYP2C19 P33261 2/20 0.36
PDK4 Q16654 2/20 0.36
CYP3A43 Q9HB55 2/20 0.36
OGFRL1 Q5TC84 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7891277 0.84 HTR2A (0.38) HTR2CHTR2BHTR2AOPRM1OPRD1
SCHEMBL12049958 0.82 HTR2C (0.45) HTR2CHTR2BHTR2AOPRM1DRD2
SCHEMBL7902547 0.78 OPRL1 (0.56) OPRM1OPRK1OPRL1DRD2MAPT
SCHEMBL15848120 0.77 DRD2 (0.58) HTR2CHTR2BHTR2ADRD2SLC6A4
SCHEMBL31352052 0.74 CYP1A2 (0.49) HTR2CHTR2BHTR2AOPRM1CYP1A2
SCHEMBL3440231 0.74 CYP1A2 (0.49) HTR2CHTR2BHTR2AOPRM1CYP1A2
SCHEMBL18175772 0.73 HTR2C (0.53) HTR2CHTR2BHTR2AALDH1A1MAPT
Hydrochloric Acid SCHEMBL3195312 0.73 CYP1A2 (0.47) HTR2CHTR2BHTR2AOPRM1CYP1A2
SCHEMBL2604439 0.71 DRD2 (0.43) HTR2CHTR2BHTR2ADRD2SLC6A4
SCHEMBL20230066 0.71 HTR2C (0.43) HTR2CHTR2BHTR2ADRD2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163239-B1 MODIFIED AMINO-ACID AMIDES AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM PHARMA (DE) 2003-05-28 EP disclosed
US-6313097-B1 TREATMENT OR PROPHYLAXIS OF MIGRAINE OR CLUSTER HEADACHES, NON-INSULIN-DEPENDENT DIABETES MELLITUS, INFLAMMATION, ALLERGIC RHINITIS, ASTHMA, MORPHINE TOLERANCE, MENOPAUSAL HOT FLASHES, DISEASES CHARACTERIZED BY EXCESSIVE VASODILATATION BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-06 US disclosed